United Kingdom · Question · Written question
UIN 5502
Palforzia
Original
Introduced
11 September 2024
Last action
8 October 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
8 October 2024
Summary
To ask the Secretary of State for Health and Social Care, what the NHS geographic availability is of Palforzia as of September 2024; and if he will publish a regional breakdown the number of people that received Palforzia on the NHS since 2022.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 September 2024
Written question
To ask the Secretary of State for Health and Social Care, what the NHS geographic availability is of Palforzia as of September 2024; and if he will publish a regional breakdown the number of people that received Palforzia on the NHS since 2022.
Source: Commons
8 October 2024
Answer
Palforzia is a peanut immunotherapy drug that helps reduce the severity of children's allergic reactions that may occur with exposure to peanuts. Data on the number and geographical location of children that have had access to Palforzia in England is not ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-09-11/5502
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1729016
- uk · wq-1729016 · source updated 8 October 2024